Koos Boeve

196 Chapter 9 with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2008 Oct;265(10):1147-1153. 67. Dasgupta A, Lim AR, Ghajar CM. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol 2017 Jan;11(1):40-61. 68. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011 Jan;11(1):9- 22. 69. Gao XL, Zhang M, Tang YL, Liang XH. Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis. Onco Targets Ther 2017 Oct 27;10:5219-5228. 70. Sproll C, Fluegen G, Stoecklein NH. Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer. Adv Exp Med Biol 2018;1100:55-82. 71. Kaifi JT, Li G, Clawson G, Kimchi ET, Staveley-O’Carroll KF. Perioperative circulating tumor cell detection: Current perspectives. Cancer Biol Ther 2016 Aug 2;17(8):859-869. 72. Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009 Jun 20;27(18):2946-2953. 73. Cserni G, Chmielik E, Cserni B, Tot T. The new TNM-based staging of breast cancer. Virchows Arch 2018 May;472(5):697-703. 74. Dutch guidelines breast cancer. 2018; Available at: https://richtlijnendatabase.nl/ richtlijn/borstkanker/invasief_carcinoom. html. Accessed August 08, 2019. 75. Den Toom IJ, Bloemena E, van Weert S, Karagozoglu KH, Hoekstra OS, de Bree R. Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes. Eur Arch Otorhinolaryngol 2017 Feb;274(2):961-968. 76. Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg 2016 Sep;264(3):413-420. 77. Esteller M. Epigenetics in cancer. N Engl J Med 2008 Mar 13;358(11):1148-1159. 78. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 2012 Nov 20;30(33):4104-4110. 79. Noorlag R, van Kempen PM, Stegeman I, Koole R, van Es RJ, Willems SM. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis. Virchows Arch 2015 Apr;466(4):363-373. 80. Noorlag R, Boeve K, Witjes MJ, Koole R, Peeters TL, Schuuring E, et al. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer. Head Neck 2017 Feb;39(2):326-333. 81. Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, et al. Amplicon mapping and